AZN Jul 2023 45.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:36PM EST. Market open.
| Previous Close | 0.2700 |
| Open | 0.2700 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 45.00 |
| Expire Date | 2023-07-21 |
| Day's Range | 0.2700 - 0.2700 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
- Motley Fool
Could This Vaccine Become Sanofi's Latest Blockbuster?
Sanofi (NASDAQ: SNY) and AstraZeneca's (NASDAQ: AZN) application for the respiratory syncytial virus (RSV) vaccine candidate called nirsevimab was recently accepted for review by the U.S. Food and Drug Administration (FDA) as a protective option for all infants. Nirsevimab is known by the trade name Beyfortus in the European Union and the United Kingdom, and the FDA expects to make an approval decision on the RSV vaccine in the third quarter of this year.
- Zacks
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know
Astrazeneca (AZN) closed the most recent trading day at $65.53, moving -0.7% from the previous trading session.
- The Telegraph
The man behind AstraZeneca’s ‘blockbuster’ cancer drugs
As far as life goals go, defeating cancer might be deemed one of the more fanciful.
© 2023 Yahoo. All rights reserved.
